The Latest Breaking News from FDA

Studies suggest people who take metformin for diabetes may be at lower risk for cancer, heart disease and dementia. Now researchers aim to test if it prevents age-related diseases in healthy people.

Public health authorities are investigating reports of counterfeit injections sickening 19 people across nine states. Experts say getting bona fide Botox starts with finding a trustworthy provider.

The CDC has received reports of 12 Salmonella infections in seven states.

The Food and Drug Administration warns Trader Joe's customers in dozens of states to throw out fresh basil after a federal investigation linked the product to a salmonella outbreak.

There is currently no similar required testing in place

Eli Lilly's Zepbound drug shows promise in treating obstructive sleep apnea by reducing symptoms and promoting weight loss.

A lawsuit filed against HHS for lack of transparency in proposed menthol cigarette regulations, sparking debate and concerns about the impact on minority c...

Officials said that all the incidents involved women who reported sick following the administration of counterfeit Botox injections of AbbVie or those who received injections from unlicensed or untrained individuals in non-healthcare environments.

CDC warns of adverse reactions to cosmetic injections, stressing caution and proper verification. Learn about botulism risks and safety measures.

Investing in penny stocks carries substantial risk, but also offers the potential for significant returns. These penny stocks, all with bullish analyst ratings, have considerable upside potential, according to Wall Street.

The biotech sector’s robust long-term growth is driven by strong government support, the rising foothold of personalized medicine, the growing number of orphan drug formulations, and rapid AI adoption. Hence, biotech stocks G1 Therapeutics (GTHX), Vanda Pharmaceuticals (VNDA), and Royalty Pharma (RPRX) could be ideal additions to your watchlist. Keep…